Experimental sensory neuropathy induced by sensitization with ganglioside GD1b

Three of six rabbits immunized with purified GD1b developed ataxic sensory neuropathy. They laid on the floor with their limbs splayed out, and their movements were awkward; but muscle power, tonus, and superficial sensation appeared to be intact. Sciatic nerve motor conduction studies were normal. Axonal degeneration was present in the dorsal column of the spinal cord, in the dorsal roots, and in the sciatic nerve. Some of the nerve cell bodies in the dorsal root ganglia had degenerated and disappeared. No demyelinative lesions or mononuclear cell infiltrations were seen in those regions. No pathological changes were present in the other three immunized rabbits that showed no clinical symptoms. Control rabbits inoculated only with adjuvants showed neither clinical symptoms nor pathological changes. Anti‐GD1b antibody was raised in the sera from all six rabbits immunized with GD1b. The monoclonal anti‐GD1b antibody GGR12 immuno‐stained about one‐half the rabbit primary sensory neurons. Sensitization with GD1b, therefore, may cause ataxic sensory neuropathy in rabbits due to antibody‐mediated damage to the primary sensory neurons.

[1]  H. Willison,et al.  Multifocal motor neuropathy human sera block distal motor nerve conduction in mice , 1995, Annals of neurology.

[2]  I. Kanazawa,et al.  Anti‐gal‐C antibody in autoimmune neuropathies subsequent to mycoplasma infection , 1995, Muscle & nerve.

[3]  H. Hartung,et al.  Immunopathogenesis and treatment of the guillain‐barré syndrome—part I , 1995, Muscle & nerve.

[4]  I. Kanazawa,et al.  N‐acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain‐Barré syndrome , 1994, Annals of neurology.

[5]  H. Willison,et al.  Peripheral neuropathy associated with monoclonal IgM anti-Pr2 cold agglutinins. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[6]  I. Kanazawa,et al.  Serum anti‐GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain‐Barré syndrome , 1993, Neurology.

[7]  I. Kanazawa,et al.  Localization of GM1 and GD1b antigens in the human peripheral nervous system , 1993, Muscle & nerve.

[8]  I. Kanazawa,et al.  Acute conduction block in vitro following exposure to antiganglioside sera , 1993, Muscle & nerve.

[9]  S. Kusunoki,et al.  IgM M‐protein in a patient with sensory‐dominant neuropathy binds preferentially to polysialogangliosides , 1992, Acta neurologica Scandinavica.

[10]  H. Ozawa,et al.  Generation of one set of monoclonal antibodies specific for b-pathway ganglio-series gangliosides. , 1992, Biochimica et biophysica acta.

[11]  S. Kusunoki,et al.  Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome , 1992, Annals of neurology.

[12]  M. Weller,et al.  Influence of gangliosides on experimental allergic neuritis , 1992, Journal of Neuroimmunology.

[13]  M. Dalakas,et al.  Sensory neuropathy associated with monoclonal immunoglobulin M to GD1b ganglioside , 1992, Annals of neurology.

[14]  S. Staugaitis,et al.  Experimental conduction block induced by serum from a patient with anti‐GM1 antibodies , 1992, Annals of neurology.

[15]  M. Dalakas,et al.  Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy , 1992, Journal of the Neurological Sciences.

[16]  D. Ponzin,et al.  Effects of gangliosides on the expression of autoimmune demyelination in the peripheral nervous system , 1991, Annals of neurology.

[17]  A. Pestronk,et al.  Invited review: motor neuropathies, motor neuron disorders, and antiglycolipid antibodies. , 1991, Muscle & nerve.

[18]  R. Hughes,et al.  Association between glycoconjugate antibodies and Campylobacter infection in patients with Guillain-Barré syndrome , 1991, Journal of Neuroimmunology.

[19]  T. Miyatake,et al.  Acute axonal polyneuropathy associated with anti‐GM1 antibodies following Campylobacter enteritis , 1990, Neurology.

[20]  S. Kusunoki,et al.  Motor dominant neuropathy and IgM paraproteinemia: the IgM M-protein binds to specific gangliosides , 1989, Journal of Neuroimmunology.

[21]  T. Kohriyama,et al.  Preparation and Characterization of Antibodies Against a Sulfated Glucuronic Acid‐Containing Glycosphingolipid , 1988, Journal of neurochemistry.

[22]  G. McKhann,et al.  Serum antibodies to gangliosides in guillain‐barré syndrome , 1988, Annals of neurology.

[23]  R. Brady,et al.  Monoclonal IgM in a patient with paraproteinemic polyneuropathy binds to gangliosides containing disialosyl groups , 1985, Annals of neurology.

[24]  S. Ando Gangliosides in the nervous system , 1983, Neurochemistry International.

[25]  Y. Hirabayashi,et al.  A new method for purification of anti-glycosphingolipid antibody. Avian anti-hematoside (NeuGc) antibody. , 1983, Journal of biochemistry.

[26]  D. Silberberg,et al.  Experimental allergic neuritis induced by sensitization with galactocerebroside. , 1979, Science.

[27]  Masaki Saito,et al.  Ganglioside syndrome, a new autoimmune neurologic disorder, experimentally induced with brain gangliosides , 1976, Neuroscience Letters.